Microbot Medical (MBOT) Competitors $2.52 +0.02 (+0.80%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBOT vs. CLPT, OM, CATX, SNWV, NNOX, NYXH, SMTI, SKIN, ZIMV, and TCMDShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include ClearPoint Neuro (CLPT), Outset Medical (OM), Perspective Therapeutics (CATX), Sanuwave Health (SNWV), Nano-X Imaging (NNOX), Nyxoah (NYXH), Sanara MedTech (SMTI), Beauty Health (SKIN), ZimVie (ZIMV), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry. Microbot Medical vs. Its Competitors ClearPoint Neuro Outset Medical Perspective Therapeutics Sanuwave Health Nano-X Imaging Nyxoah Sanara MedTech Beauty Health ZimVie Tactile Systems Technology ClearPoint Neuro (NASDAQ:CLPT) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends. Which has more volatility & risk, CLPT or MBOT? ClearPoint Neuro has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Does the media favor CLPT or MBOT? In the previous week, Microbot Medical had 4 more articles in the media than ClearPoint Neuro. MarketBeat recorded 6 mentions for Microbot Medical and 2 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 1.90 beat Microbot Medical's score of 0.67 indicating that ClearPoint Neuro is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ClearPoint Neuro 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Microbot Medical 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in CLPT or MBOT? 30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 6.1% of ClearPoint Neuro shares are held by insiders. Comparatively, 4.7% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is CLPT or MBOT more profitable? Microbot Medical has a net margin of 0.00% compared to ClearPoint Neuro's net margin of -64.51%. ClearPoint Neuro's return on equity of -78.09% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets ClearPoint Neuro-64.51% -78.09% -51.33% Microbot Medical N/A -110.27%-94.20% Do analysts rate CLPT or MBOT? ClearPoint Neuro currently has a consensus price target of $25.00, indicating a potential upside of 109.38%. Microbot Medical has a consensus price target of $9.00, indicating a potential upside of 257.14%. Given Microbot Medical's higher probable upside, analysts plainly believe Microbot Medical is more favorable than ClearPoint Neuro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ClearPoint Neuro 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Microbot Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, CLPT or MBOT? Microbot Medical has lower revenue, but higher earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearPoint Neuro$31.39M10.65-$18.91M-$0.76-15.71Microbot MedicalN/AN/A-$11.44M-$0.65-3.88 SummaryClearPoint Neuro and Microbot Medical tied by winning 7 of the 14 factors compared between the two stocks. Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$90.94M$6.74B$5.45B$8.90BDividend YieldN/A1.04%5.36%4.14%P/E Ratio-3.8826.1426.3419.65Price / SalesN/A76.71406.69110.21Price / CashN/A21.4025.8827.49Price / Book14.824.757.925.42Net Income-$11.44M$171.62M$3.15B$248.34M7 Day Performance6.78%1.78%2.20%2.41%1 Month Performance-2.33%-0.92%4.39%4.80%1 Year Performance147.06%18.96%32.26%17.50% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical1.9922 of 5 stars$2.52+0.8%$9.00+257.1%+145.1%$90.94MN/A-3.8820CLPTClearPoint Neuro2.2686 of 5 stars$11.36+0.9%$25.00+120.1%+118.9%$317.97M$31.39M-14.95110OMOutset Medical1.5004 of 5 stars$17.37-8.5%$27.00+55.4%-67.0%$307.83M$115.27M-0.60520High Trading VolumeCATXPerspective Therapeutics2.3161 of 5 stars$4.11+18.8%$12.56+205.5%-62.3%$305.08M$1.43M0.0070SNWVSanuwave HealthN/A$33.57-0.3%N/AN/A$287.36M$32.63M-7.3740High Trading VolumeNNOXNano-X Imaging2.3594 of 5 stars$4.95-0.8%$9.50+91.9%-28.7%$286.01M$11.28M-5.50190NYXHNyxoah3.1882 of 5 stars$7.83+1.6%$14.50+85.2%+7.2%$266.69M$4.89M-3.68110Positive NewsGap UpSMTISanara MedTech2.2084 of 5 stars$27.82+2.0%$49.50+77.9%+0.7%$247.26M$91.57M-20.7660SKINBeauty Health0.3293 of 5 stars$1.93+19.9%$1.42-26.6%+1.6%$243.16M$334.30M-4.711,030High Trading VolumeZIMVZimVie2.4667 of 5 stars$8.65-1.6%$16.33+88.8%-49.3%$240.90M$449.75M-12.181,770Analyst UpgradeTCMDTactile Systems Technology3.2808 of 5 stars$10.17+2.0%$16.00+57.3%-13.4%$236.45M$292.98M15.411,037 Related Companies and Tools Related Companies ClearPoint Neuro Alternatives Outset Medical Alternatives Perspective Therapeutics Alternatives Sanuwave Health Alternatives Nano-X Imaging Alternatives Nyxoah Alternatives Sanara MedTech Alternatives Beauty Health Alternatives ZimVie Alternatives Tactile Systems Technology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBOT) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
